Showing results (21-30 of 87) with videos related to

Sort By:
Pageof 9
Anti-Cancer Drugs|October 21, 2004
Peripheral neuropathy associated with capecitabineM Wasif Saif, Tina E Wood, Philip J McGee, et al.
Cancer Chemotherapy and Pharmacology|January 20, 2006
Dihydropyrimidine dehydrogenase deficiency in an Indian populationMuhammad Wasif Saif, Lori Mattison, Tom Carollo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Capecitabine induces rapid, sustained response in two patients with extensive oral verrucous carcinomaAnastasios Salesiotis, Richie Soong, Robert B Diasio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2005
Methylation of the DPYD promoter: an alternative mechanism for dihydropyrimidine dehydrogenase deficiency in cancer patientsHany H Ezzeldin, Adam M Lee, Lori K Mattison, et al.
Cancer Chemotherapy and Pharmacology|December 14, 2006
DPYD*2A mutation: the most common mutation associated with DPD deficiencyM W Saif, Hany Ezzeldin, Katisha Vance, et al.
Pakistan Journal of Medical Sciences|October 11, 2008
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY (DPD) IN GI MALIGNANCIES: EXPERIENCE OF 4-YEARSM Wasif Saif, Kostas Syrigos, Ranee Mehra, et al.
Anti-Cancer Drugs|September 27, 2006
Peripheral neuropathy exacerbation associated with topical 5-fluorouracilMuhammad Wasif Saif, Shahrukh Hashmi, Lori Mattison, et al.
Biochimica Et Biophysica Acta|June 30, 2006
The role of Sp1 and Sp3 in the constitutive DPYD gene expressionXue Zhang, Lin Li, Jeanne Fourie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
Rapid identification of dihydropyrimidine dehydrogenase deficiency by using a novel 2-13C-uracil breath testLori K Mattison, Hany Ezzeldin, Mark Carpenter, et al.
Pageof 9